Literature DB >> 20083005

Triggering endogenous neuroprotective processes through exercise in models of dopamine deficiency.

Michael J Zigmond1, Judy L Cameron, Rehana K Leak, Karoly Mirnics, Vivienne A Russell, Richard J Smeyne, Amanda D Smith.   

Abstract

We are testing the hypothesis that exercise is neuroprotective in animal models of the dopamine (DA) deficiency in Parkinson's disease. Our studies include mice or rats provided access to a running wheel and subsequently treated with MPTP (mice) or 6-hydroxydopamine (rats) and monkeys provided access to a treadmill and subsequently treated with MPTP. Typically, the exercise occurs for 3 months prior to the toxin treatment and often for 1-2 months thereafter. Our findings indicate that exercise reduces the behavioral impairments elicited by the dopaminergic neurotoxins as well as the loss of DA neurons as assessed by PET imaging and biochemical or histochemical assessment of tissue samples. Our studies are focused on one of several possible explanations for the beneficial effects of exercise: an exercise-induced increase in the expression of neurotrophic factors, particularly GDNF. Our observations indicate that GDNF can reduce the vulnerability of DA neurons, in part due to the activation of key intracellular cascades. We also find that mild cellular stress itself can provide protection against more intensive stress, a form of preconditioning. We conclude that dopamine neurons have the capacity to respond to intracellular and extracellular signals by triggering endogenous neuroprotective mechanisms. This raises the possibility that some individuals with Parkinson's disease suffer from a reduction of these neuroprotective mechanisms, and that treatments that boost these mechanisms - including exercise - may provide therapeutic benefit.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20083005     DOI: 10.1016/S1353-8020(09)70778-3

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  42 in total

1.  Delayed exercise-induced functional and neurochemical partial restoration following MPTP.

Authors:  Trevor Archer; Anders Fredriksson
Journal:  Neurotox Res       Date:  2011-08-10       Impact factor: 3.911

Review 2.  The influence of skeletal muscle on systemic aging and lifespan.

Authors:  Fabio Demontis; Rosanna Piccirillo; Alfred L Goldberg; Norbert Perrimon
Journal:  Aging Cell       Date:  2013-07-17       Impact factor: 9.304

Review 3.  Voluntary exercise delays progressive deterioration of markers of metabolism and behavior in a mouse model of Parkinson's disease.

Authors:  Jing-Huei Lai; Kai-Yun Chen; John Chung-Che Wu; Lars Olson; Stefan Brené; Chi-Zong Huang; Yen-Hua Chen; Shuo-Jhen Kang; Kuo-Hsing Ma; Barry J Hoffer; Tsung-Hsun Hsieh; Yung-Hsiao Chiang
Journal:  Brain Res       Date:  2019-06-18       Impact factor: 3.252

Review 4.  Preconditioning provides neuroprotection in models of CNS disease: paradigms and clinical significance.

Authors:  R Anne Stetler; Rehana K Leak; Yu Gan; Peiying Li; Feng Zhang; Xiaoming Hu; Zheng Jing; Jun Chen; Michael J Zigmond; Yanqin Gao
Journal:  Prog Neurobiol       Date:  2014-01-02       Impact factor: 11.685

Review 5.  The interaction between stress and exercise, and its impact on brain function.

Authors:  Vivienne A Russell; Michael J Zigmond; Jacqueline J Dimatelis; William M U Daniels; Musa V Mabandla
Journal:  Metab Brain Dis       Date:  2014-01-08       Impact factor: 3.584

6.  The Impact of Short and Long-Term Exercise on the Expression of Arc and AMPARs During Evolution of the 6-Hydroxy-Dopamine Animal Model of Parkinson's Disease.

Authors:  P C Garcia; C C Real; L R Britto
Journal:  J Mol Neurosci       Date:  2017-02-28       Impact factor: 3.444

7.  Adaptation and sensitization to proteotoxic stress.

Authors:  Rehana K Leak
Journal:  Dose Response       Date:  2013-08-05       Impact factor: 2.658

8.  Reactive astrocytes and Wnt/β-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

Authors:  F L'Episcopo; C Tirolo; N Testa; S Caniglia; M C Morale; C Cossetti; P D'Adamo; E Zardini; L Andreoni; A E C Ihekwaba; P A Serra; D Franciotta; G Martino; S Pluchino; B Marchetti
Journal:  Neurobiol Dis       Date:  2010-11-05       Impact factor: 5.996

9.  Study in Parkinson disease of exercise (SPARX): translating high-intensity exercise from animals to humans.

Authors:  Charity G Moore; Margaret Schenkman; Wendy M Kohrt; Anthony Delitto; Deborah A Hall; Daniel Corcos
Journal:  Contemp Clin Trials       Date:  2013-06-14       Impact factor: 2.226

10.  Non-exercise physical activity attenuates motor symptoms in Parkinson disease independent from nigrostriatal degeneration.

Authors:  Jonathan Snider; Martijn L T M Müller; Vikas Kotagal; Robert A Koeppe; Peter J H Scott; Kirk A Frey; Roger L Albin; Nicolaas I Bohnen
Journal:  Parkinsonism Relat Disord       Date:  2015-08-28       Impact factor: 4.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.